MedTrace Logo

Place of Copeptin-troponin Assay in the Elimination Diagnosis of Non-ST+ ACS

NCT05902117 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2025-03-18

No results posted yet for this study

Summary

The aim of this study is to demonstrate that a combined troponin and copeptin assay can exclude non-ST+ ACS in patients with chest pain less than 6 hours old.

Conditions

  • Acute Myocardial Infarction

Interventions

DIAGNOSTIC_TEST

Troponin and Copeptin assay

Collection of an additional blood tube for copeptin determination during blood collection for troponin testing as part of care.

Sponsors & Collaborators

  • Hôpital NOVO

    lead OTHER

Principal Investigators

  • Dr Olivier Fancelli · NOVO Hospital - Pontoise Site

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-28
Primary Completion
2025-02-28
Completion
2025-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05902117 on ClinicalTrials.gov